Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis

BACKGROUND: Proton pump inhibitors (PPIs) are commonly used in the treatment of acid-related diseases; however, the association between the use of PPIs and potential risk of hypomagnesemia is controversial. METHODS: In the present study, databases including PubMed, EMBASE, MEDLINE, PsycINFO, CINAHL,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Shengtao, Gan, Li, Mei, Zhechuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456119/
https://www.ncbi.nlm.nih.gov/pubmed/30921222
http://dx.doi.org/10.1097/MD.0000000000015011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456119/
https://www.ncbi.nlm.nih.gov/pubmed/30921222
http://dx.doi.org/10.1097/MD.0000000000015011

Ejemplares similares